Reconciled ClinicalTrials.gov v2 Protocol Specification
| Protocol Field | Verified Registry Value |
|---|---|
| NCT Identifier | NCT05193916 |
| Consolidated Lead Sponsor | Chipscreen Biosciences |
| Therapeutic Condition Cohort | Endocrinology, Obesity, and Metabolic |
| Clinical Trial Phase | Phase II |
| Overall Recruitment Status | COMPLETED |
| Registered Enrollment | 104 participants (ACTUAL) |
| Registered Start Date | 2022-03-21 |
| WhyStopped Classification | Not Stopped |
Named U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Site Profile |
|---|---|---|
| Beijing Friendship Hospital , Capital Medical University | Beijing, China | Open Hospital Dossier -> |
| Peking University People's Hospital | Beijing, China | Open Hospital Dossier -> |
| The First Hospital of Lanzhou University | Lanzhou, China | Open Hospital Dossier -> |
| The First Affiliated Hospital of Sun Yat-sen University | Guangzhou, China | Open Hospital Dossier -> |
Search related sites and sponsors in the Interactive Directory, explore Endocrinology, Obesity, and Metabolic Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.